The chart below shows how SMLR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, SMLR sees a +0.61% change in stock price 10 days leading up to the earnings, and a -9.75% change 10 days following the report. On the earnings day itself, the stock moves by -2.06%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Earnings Per Share Surprise: Semler Scientific reported an impressive EPS of $3.41, significantly exceeding expectations of $0.26.
Record Cash Generation: The company achieved record cash generation of over $24 million in 2024 from its healthcare operations.
Bitcoin Treasury Adoption: Semler adopted Bitcoin as its primary treasury reserve asset in May 2024, becoming the second U.S. public company to do so.
Bitcoin Treasury Strategy Impact: Since adopting the Bitcoin treasury strategy, the company has made substantial purchases, owning 3,192 bitcoins valued at over $300 million.
Bitcoin Treasury Yield Growth: The Bitcoin treasury strategy has generated a positive yield of 152% since its adoption.
Market Cap Surge: Semler Scientific's market capitalization has grown by more than 200% since adopting Bitcoin nine months ago.
Product Innovation Initiative: The company is seeking a new 510(k) clearance for a product extension of its QuantaFlo technology, indicating ongoing innovation.
Cardiovascular Revenue Expansion: Semler is pursuing additional revenue opportunities in the cardiovascular space, leveraging its established customer base.
Negative
Bitcoin Treasury Adoption Risks: The company has adopted Bitcoin as its primary treasury reserve asset, which may expose it to significant volatility and risks associated with cryptocurrency investments.
Bitcoin Reliance Risks Operations: Despite strong earnings, the reliance on Bitcoin for treasury management could divert focus from core healthcare operations and product development.
Bitcoin Investment Risks: The company has made substantial investments in Bitcoin, which could impact liquidity and financial stability if the cryptocurrency market experiences downturns.
Product Development Challenges: The announcement of seeking a new 510(k) clearance indicates that the company may be facing challenges in its product development pipeline.
Investment Prioritization Concerns: The mention of monetizing a minority investment in Monarch Medical to fund Bitcoin purchases raises concerns about the prioritization of cryptocurrency over traditional business investments.
Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 Earnings Call Transcript
SMLR.O
3.02%